OncoCyte Corp.
(NYSE Amex Equities : OCX)

( )
OCX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
0.29%95.750.6%$578.30m
ABTAbbott Laboratories
1.02%72.570.8%$496.37m
ISRGIntuitive Surgical, Inc.
1.49%515.632.4%$402.42m
TMOThermo Fisher Scientific Inc.
1.61%241.321.0%$389.37m
BAXBaxter International Inc.
1.21%66.991.7%$319.84m
ALGNAlign Technology, Inc.
-0.45%219.296.3%$294.66m
BSXBoston Scientific Corporation
1.48%37.101.1%$294.20m
DXCMDexCom, Inc.
1.21%124.528.5%$282.64m
BDXBecton, Dickinson and Company
-0.43%235.641.1%$261.37m
EWEdwards Lifesciences Corporation
-0.01%163.181.2%$234.05m
SYKStryker Corporation
0.58%172.651.3%$233.25m
ABMDABIOMED, Inc.
0.78%330.693.3%$228.42m
ZBHZimmer Biomet Holdings, Inc.
0.84%112.951.7%$127.75m
XRAYDENTSPLY International Inc.
3.03%38.123.1%$107.77m
WATWaters Corporation
0.31%190.373.5%$106.34m

Company Profile

OncoCyte Corp. is a pharmaceutical company. It is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company was founded in September 2009 and is headquartered in Alameda, CA.